{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:10:27Z","timestamp":1784675427443,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Immunogenic causes of inflammation may be difficult to differentiate in the work-up of orbital inflammatory disease. The study aims to investigate the utility of autoimmune markers in the screening for orbital inflammation. Markers studied included angiotensin-converting enzyme (ACE), antinuclear antibody (ANA), anti-neutrophilic cytoplasmic autoantibodies (ANCA), extractable nuclear antigen (ENA), anti-cyclic citrullinated peptide (Anti-CCP) and anti-double stranded DNA antibody (Anti-dsDNA antibody).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective single-centre study of consecutive patients with non-infective orbital inflammation screened for autoimmune markers at presentation. Serology was interpreted alongside clinical course and other investigations (e.g. radiographic features and histopathology). Tabulated data and Pearson\u2019s Chi-square allowed analysis of trends between serology, diagnosis and the decision to biopsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>79 patients, between 1999 and 2021, were included (50 females, mean age was 50.4\u2009\u00b1\u200917.4 years). 28 (34.6%) patients had specific orbital inflammation and 53 (65.4%) patients had non-specific orbital inflammation (NSOI). Of the 12 patients with positive serology and a specific diagnosis, only 5 (41.7%) patients had concordant serological results. There was no association between serology results and the patient undergoing biopsy (<jats:italic>P<\/jats:italic>\u2009=\u20090.651). Serology was unable to exclude nor differentiate NSOI from other specific conditions and ANA had limited discriminatory value between specific conditions and NSOI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Serological testing alone may not provide a clear direction for further investigation of orbital inflammation and a biopsy may occur independently of the serological results. The value of autoimmune markers may lie in subsequent follow-up as patients may develop suggestive symptoms after an indeterminate positive result or initially seronegative disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-022-02068-5","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:17:08Z","timestamp":1650352628000},"page":"1088-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune markers in screening for orbital inflammatory disease"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-1793","authenticated-orcid":false,"given":"Terence","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Juniat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"2068_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/17469899.2016.1233399","volume":"11","author":"GrantH Moore","year":"2016","unstructured":"Moore GrantH, Rootman, Daniel B. Orbital inflammatory disease management. Expert Rev Ophthalmol. 2016;11:415\u201328.","journal-title":"Expert Rev Ophthalmol"},{"key":"2068_CR2","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/sj.eye.6702383","volume":"20","author":"LK Gordon","year":"2006","unstructured":"Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye 2006;20:1196\u2013206.","journal-title":"Eye"},{"key":"2068_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.survophthal.2016.03.002","volume":"61","author":"I Mombaerts","year":"2016","unstructured":"Mombaerts I, Rose GE, Garrity JA. Orbital inflammation: Biopsy first. Surv Ophthalmol. 2016;61:664\u20139.","journal-title":"Surv Ophthalmol"},{"key":"2068_CR4","unstructured":"Rootman J. Diseases of the orbit: a multidisciplinary approach. 2nd ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2002. p. 586."},{"key":"2068_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ajo.2004.09.032","volume":"138","author":"PA Rubin","year":"2004","unstructured":"Rubin PA, Foster CS. Etiology and Management of Idiopathic Orbital Inflammation. Am J Ophthalmo. 2004;138:1041\u20133.","journal-title":"Am J Ophthalmo"},{"key":"2068_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"2068_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum. 1990;33:1101\u20137.","journal-title":"Arthritis Rheum"},{"key":"2068_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3174\/ajnr.A1315","volume":"30","author":"R Kapur","year":"2009","unstructured":"Kapur R, Sepahdari AR, Mafee MF, Putterman AM, Aakalu V, Wendel LJ, et al. MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol. 2009;30:64\u201370.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2068_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3174\/ajnr.A1315","volume":"30","author":"R Kapur","year":"2009","unstructured":"Kapur R, Sepahdari AR, Mafee MF, Putterman AM, Aakalu V, Wendel LJA, et al. MR Imaging of Orbital Inflammatory Syndrome, Orbital Cellulitis, and Orbital Lymphoid Lesions: The Role of Diffusion-Weighted Imaging. Am J Neuroradiol. 2009;30:64\u201370.","journal-title":"Am J Neuroradiol"},{"key":"2068_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00234-018-2103-4","volume":"60","author":"TA Ferreira","year":"2018","unstructured":"Ferreira TA, Saraiva P, Genders SW, Buchem MV, Luyten GPM, Beenakker JW. CT and MR imaging of orbital inflammation. Neuroradiology 2018;60:1253\u201366.","journal-title":"Neuroradiology"},{"key":"2068_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IOP.0000000000000701","volume":"33","author":"A Srinivasan","year":"2017","unstructured":"Srinivasan A, Kleinberg TT, Murchison AP, Jurij R. Bilyk. Laboratory Investigations for Diagnosis of Autoimmune and Inflammatory Periocular Disease: Part II. Ophthalmic Plast Reconstr Surg. 2017;33:1\u20138.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2068_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/IOP.0000000000000697","volume":"32","author":"A Srinivasan","year":"2016","unstructured":"Srinivasan A, Kleinberg TT, Murchison AP, Bilyk JR. Laboratory Investigations for Diagnosis of Autoimmune and Inflammatory Periocular Disease: Part I. Ophthalmic Plast Reconstr Surg. 2016;32:321\u20138.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2068_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajo.2007.07.019","volume":"144","author":"I Mavrikakis","year":"2007","unstructured":"Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol. 2007;144:769\u201375.","journal-title":"Am J Ophthalmol"},{"key":"2068_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0039-6257(84)90186-3","volume":"28","author":"RN Weinreb","year":"1984","unstructured":"Weinreb RN, Tessler H. Laboratory diagnosis of ophthalmic sarcoidosis. Surv Ophthalmol. 1984;28:653\u201364.","journal-title":"Surv Ophthalmol"},{"key":"2068_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","volume":"59","author":"J Lieberman","year":"1975","unstructured":"Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365\u201372.","journal-title":"Am J Med"},{"key":"2068_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0002-9394(86)90002-4","volume":"102","author":"JM Collison","year":"1986","unstructured":"Collison JM, Miller NR, Green WR. Involvement of orbital tissues by sarcoid. Am J Ophthalmol. 1986;102:302\u20137.","journal-title":"Am J Ophthalmol"},{"key":"2068_CR17","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.ophtha.2014.04.018","volume":"121","author":"SX Tang","year":"2014","unstructured":"Tang SX, Lim RP, Al-Dahmash S, Blaydon SM, Cho RI, Choe CH, et al. Bilateral lacrimal gland disease: clinical features of 97 cases. Ophthalmology 2014;121:2040\u20136.","journal-title":"Ophthalmology"},{"key":"2068_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/10408369109106868","volume":"28","author":"B B\u00e9n\u00e9teau-Burnat","year":"1991","unstructured":"B\u00e9n\u00e9teau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci. 1991;28:337\u201356.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2068_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/01676830.2013.771676","volume":"32","author":"MP Rabinowitz","year":"2013","unstructured":"Rabinowitz MP, Halfpenny CP, Bedrossian EH Jr. The frequency of granulomatous lacrimal gland inflammation as a cause of lacrimal gland enlargement in patients without a diagnosis of systemic sarcoidosis. Orbit 2013;32:151\u20135.","journal-title":"Orbit"},{"key":"2068_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","volume":"126","author":"AM Abeles","year":"2013","unstructured":"Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med. 2013;126:342\u20138.","journal-title":"Am J Med"},{"key":"2068_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","volume":"25","author":"N Nardi","year":"2006","unstructured":"Nardi N, Brito-Zer\u00f3n P, Ramos-Casals M, Aguil\u00f3 S, Cervera R, Ingelmo M, et al. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sj\u00f6gren\u2019s syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol. 2006;25:341\u20136.","journal-title":"Clin Rheumatol"},{"key":"2068_CR22","first-page":"57","volume":"38","author":"SA Lyne","year":"2020","unstructured":"Lyne SA, Downie-Doyle S, Lester SE, Quinlivan A, Toby Coates P, Gordon TP, et al. Primary Sj\u00f6gren\u2019s syndrome in South Australia. Clin Exp Rheumatol. 2020;38:57\u201363.","journal-title":"Clin Exp Rheumatol"},{"key":"2068_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3","volume":"42","author":"EM Tan","year":"1999","unstructured":"Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum. 1999;42:455\u201364.","journal-title":"Arthritis Rheum"},{"key":"2068_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5114\/reum.2018.77976","volume":"56","author":"B Grygiel-G\u00f3rniak","year":"2018","unstructured":"Grygiel-G\u00f3rniak B, Rogacka N, Puszczewicz M. Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications. Reumatologia 2018;56:243\u20138.","journal-title":"Reumatologia"},{"key":"2068_CR25","unstructured":"Nosal RS, Superville SS, Varacallo M. Biochemistry, Antinuclear Antibodies (ANA). StatPearls.(Treasure Island (FL): StatPearls Publishing; 2021)."},{"key":"2068_CR26","doi-asserted-by":"publisher","first-page":"150239","DOI":"10.1155\/2014\/150239","volume":"2014","author":"M Segni","year":"2014","unstructured":"Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F. High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res. 2014;2014:150239.","journal-title":"J Immunol Res"},{"key":"2068_CR27","first-page":"1529","volume":"18","author":"M Petri","year":"1991","unstructured":"Petri M, Karlson EW, Cooper DS, Ladenson PW. Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol. 1991;18:1529\u201331.","journal-title":"J Rheumatol"},{"key":"2068_CR28","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.5858\/arpa.2013-0006-RS","volume":"138","author":"K Muller","year":"2014","unstructured":"Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings. Arch Pathol Lab Med. 2014;138:1110\u20134.","journal-title":"Arch Pathol Lab Med"},{"key":"2068_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10792-007-9109-y","volume":"28","author":"M Ahmed","year":"2008","unstructured":"Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, et al. Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation. Int Ophthalmol. 2008;28:35\u201346.","journal-title":"Int Ophthalmol"},{"key":"2068_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","volume":"23","author":"JU Holle","year":"2011","unstructured":"Holle JU, Gross WL. Neurological involvement in Wegener\u2019s granulomatosis. Curr Opin Rheumatol. 2011;23:7\u201311.","journal-title":"Curr Opin Rheumatol"},{"key":"2068_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semarthrit.2005.12.003","volume":"35","author":"N Pakrou","year":"2006","unstructured":"Pakrou N, Selva D, Leibovitch I. Wegener\u2019s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35:284\u201392.","journal-title":"Semin Arthritis Rheum"},{"key":"2068_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.7326\/0003-4819-123-12-199512150-00005","volume":"123","author":"JK Rao","year":"1995","unstructured":"Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med. 1995;123:925\u201332.","journal-title":"Ann Intern Med"},{"key":"2068_CR33","first-page":"S35","volume":"29","author":"WR Bijlsma","year":"2011","unstructured":"Bijlsma WR, Hen\u00e9 RJ, Mourits MP, Kalmann R. Orbital mass as manifestation of Wegener\u2019s granulomatosis: an ophthalmologic diagnostic approach. Clin Exp Rheumatol. 2011;29:S35\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"2068_CR34","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archopht.121.11.1640","volume":"121","author":"DW Knoch","year":"2003","unstructured":"Knoch DW, Lucarelli MJ, Dortzbach RK, Smith ME. Limited Wegener granulomatosis with 40 years of follow-up. Arch Ophthalmol. 2003;121:1640\u20132.","journal-title":"Arch Ophthalmol"},{"key":"2068_CR35","doi-asserted-by":"publisher","first-page":"643.e9","DOI":"10.1016\/j.amjmed.2006.08.016","volume":"120","author":"JD Finkielman","year":"2007","unstructured":"Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, et al. ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis. Am J Med. 2007;120:643.e9\u201314.","journal-title":"Am J Med"},{"key":"2068_CR36","first-page":"46","volume":"28","author":"JU Holle","year":"2010","unstructured":"Holle JU, Wu QJ, Moosig F, Gross WL, Csernok E. Membrane proteinase 3 (mPR3) expression on neutrophils is not increased in localized Wegener\u2019s granulomatosis (WG) and Churg-Strauss syndrome (CSS). Clin Exp Rheumatol. 2010;28:46\u201350.","journal-title":"Clin Exp Rheumatol"},{"key":"2068_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/ICU.0b013e32834bdfe2","volume":"22","author":"J Schmidt","year":"2011","unstructured":"Schmidt J, Pulido JS, Matteson EL. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol. 2011;22:489\u201395.","journal-title":"Curr Opin Ophthalmol"},{"key":"2068_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.survophthal.2009.12.003","volume":"55","author":"AB Tarabishy","year":"2010","unstructured":"Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener\u2019s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;55:429\u201344.","journal-title":"Surv Ophthalmol"},{"key":"2068_CR39","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0161-6420(01)00655-8","volume":"108","author":"TL Woo","year":"2001","unstructured":"Woo TL, Francis IC, Wilcsek GA, Coroneo MT, McNab AA, Sullivan TJ. Australasian orbital and adnexal Wegener\u2019s granulomatosis. Ophthalmology 2001;108:1535\u201343.","journal-title":"Ophthalmology"},{"key":"2068_CR40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0161-6420(97)30251-6","volume":"104","author":"SR Perry","year":"1997","unstructured":"Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology 1997;104:683\u201394.","journal-title":"Ophthalmology"},{"key":"2068_CR41","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ophtha.2013.12.003","volume":"121","author":"LT Tan","year":"2014","unstructured":"Tan LT, Davagnanam I, Isa H, Taylor SR, Rose GE, Verity DH, et al. Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement. Ophthalmology 2014;121:1304\u20139.","journal-title":"Ophthalmology"},{"key":"2068_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00002341-199911000-00022","volume":"15","author":"AB Kopstein","year":"1999","unstructured":"Kopstein AB, Kristopaitis T, Gujrati TM, Blake KA, Bouchard CS. Orbital Wegener granulomatosis without systemic findings. Ophthalmic Plast Reconstr Surg. 1999;15:467\u20139.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2068_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40123-019-0176-8","volume":"8","author":"E Sfiniadaki","year":"2019","unstructured":"Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmol Ther. 2019;8:227\u201334.","journal-title":"Ophthalmol Ther"},{"key":"2068_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0161-6420(92)32028-7","volume":"99","author":"PH Kalina","year":"1992","unstructured":"Kalina PH, Lie JT, Campbell RJ, Garrity JA. Diagnostic value and limitations of orbital biopsy in Wegener\u2019s granulomatosis. Ophthalmology 1992;99:120\u20134.","journal-title":"Ophthalmology"},{"key":"2068_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autrev.2005.05.007","volume":"5","author":"JG Damoiseaux","year":"2006","unstructured":"Damoiseaux JG, Tervaert JW. From ANA to ENA: how to proceed? Autoimmun Rev. 2006;5:10\u20137.","journal-title":"Autoimmun Rev"},{"key":"2068_CR46","first-page":"845","volume":"35","author":"H Locht","year":"2008","unstructured":"Locht H, Pelck R, Manthorpe R. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2008;35:845\u20139.","journal-title":"J Rheumatol"},{"key":"2068_CR47","doi-asserted-by":"publisher","first-page":"606195","DOI":"10.1155\/2012\/606195","volume":"2012","author":"R Yoshimi","year":"2012","unstructured":"Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y. Clinical and pathological roles of Ro\/SSA autoantibody system. Clin Dev Immunol. 2012;2012:606195.","journal-title":"Clin Dev Immunol"},{"key":"2068_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0961203318801673","volume":"27","author":"SJ Bowman","year":"2018","unstructured":"Bowman SJ. Primary Sj\u00f6gren\u2019s syndrome. Lupus 2018;27:32\u20135.","journal-title":"Lupus"},{"key":"2068_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/ard.2003.019794","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2005;64:114\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2068_CR50","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar2420","volume":"10","author":"F Atzeni","year":"2008","unstructured":"Atzeni F, Sarzi-Puttini P, Lama N, Bonacci E, Bobbio-Pallavicini F, Montecucco C, et al. Anti-cyclic citrullinated peptide antibodies in primary Sj\u00f6gren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther. 2008;10:R51.","journal-title":"Arthritis Res Ther"},{"key":"2068_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.2007.03337.x","volume":"148","author":"V Go\u00ebb","year":"2007","unstructured":"Go\u00ebb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP, et al. Clinical significance of autoantibodies recognizing Sj\u00f6gren\u2019s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol. 2007;148:281\u20137.","journal-title":"Clin Exp Immunol"},{"key":"2068_CR52","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00296-012-2572-4","volume":"33","author":"YS Ryu","year":"2013","unstructured":"Ryu YS, Park SH, Lee J, Kwok SK, Ju JH, Kim HY, et al. Follow-up of primary Sjogren\u2019s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody. Rheumatol Int. 2013;33:1443\u20136.","journal-title":"Rheumatol Int"},{"key":"2068_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5152\/eurjrheum.2020.19217","volume":"7","author":"AJ Chan","year":"2020","unstructured":"Chan AJ, Rai AS, Lake S. Orbital myositis in systemic lupus erythematosus: a case report and literature review. Eur J Rheumatol. 2020;7:135\u20137.","journal-title":"Eur J Rheumatol"},{"key":"2068_CR54","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/archopht.1983.01040010736006","volume":"101","author":"BS Grimson","year":"1983","unstructured":"Grimson BS, Simons KB. Orbital inflammation, myositis, and systemic lupus erythematosus. Arch Ophthalmol. 1983;101:736\u20138.","journal-title":"Arch Ophthalmol"},{"key":"2068_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/art.10558","volume":"47","author":"AF Kavanaugh","year":"2002","unstructured":"Kavanaugh AF, Solomon DH. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002;47:546\u201355.","journal-title":"Arthritis Rheum"},{"key":"2068_CR56","doi-asserted-by":"crossref","unstructured":"Lee MJ, Planck SR, Choi D, Harrington CA, Wilson DJ, Dailey RA, et al. Non-specific orbital inflammation: current understanding and unmet needs. Prog Retin Eye Res. 2020;81:100885.","DOI":"10.1016\/j.preteyeres.2020.100885"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02068-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:07:03Z","timestamp":1681405623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2068"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02068-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}